Product Code: ETC8849658 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The preimplantation genetic screening (PGS) technology market in the Philippines is driven by the growing demand for assisted reproductive technologies. PGS helps in selecting embryos with optimal genetic health, increasing the success rate of IVF treatments. With more couples opting for fertility treatments, the demand for genetic screening is rising. Advances in genetic testing techniques, along with increasing fertility clinic investments, are expected to further boost market growth.
The increasing prevalence of genetic disorders and the rising demand for assisted reproductive technologies are key drivers of the preimplantation genetic screening (PGS) technology market in the Philippines. As couples seek advanced fertility treatments, PGS technology is gaining traction for its ability to detect chromosomal abnormalities before embryo implantation, improving the success rates of in vitro fertilization (IVF). Additionally, growing awareness and accessibility of genetic testing services, along with advancements in screening techniques, are supporting market growth.
The adoption of PGS technology is hindered by strict regulations, high procedural costs, and limited access to advanced reproductive health services. Cultural and religious beliefs also impact the acceptance of genetic screening before implantation.
The increasing awareness and adoption of fertility treatments in the Philippines are driving demand for preimplantation genetic screening (PGS) technology. Investors can explore opportunities in diagnostic labs, fertility clinics, and genetic testing services. Companies offering cost-effective and accurate screening solutions for embryo selection have the potential to tap into a growing market supported by rising medical tourism and government initiatives in reproductive healthcare.
PGS technology is subject to government oversight to ensure compliance with ethical and medical standards. Policies restrict the use of genetic screening for non-essential traits, focusing on medical necessity. The government supports research initiatives in reproductive genetics through funding and regulatory guidance.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Preimplantation Genetic Screening (PGS) Technology Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Preimplantation Genetic Screening (PGS) Technology Market - Industry Life Cycle |
3.4 Philippines Preimplantation Genetic Screening (PGS) Technology Market - Porter's Five Forces |
3.5 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.6 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Product and Services, 2021 & 2031F |
3.8 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.10 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Preimplantation Genetic Screening (PGS) Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Preimplantation Genetic Screening (PGS) Technology Market Trends |
6 Philippines Preimplantation Genetic Screening (PGS) Technology Market, By Types |
6.1 Philippines Preimplantation Genetic Screening (PGS) Technology Market, By Procedure Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Procedure Type, 2021- 2031F |
6.1.3 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Preimplantation Genetic Screening, 2021- 2031F |
6.1.4 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Preimplantation Genetic Diagnosis, 2021- 2031F |
6.2 Philippines Preimplantation Genetic Screening (PGS) Technology Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Next-Generation Sequencing, 2021- 2031F |
6.2.3 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Polymerase Chain Reaction, 2021- 2031F |
6.2.4 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Fluorescence in Situ Hybridization, 2021- 2031F |
6.2.5 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Comparative Genomic Hybridization, 2021- 2031F |
6.2.6 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Single-Nucleotide Polymorphism, 2021- 2031F |
6.3 Philippines Preimplantation Genetic Screening (PGS) Technology Market, By Product and Services |
6.3.1 Overview and Analysis |
6.3.2 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Reagents and Consumables, 2021- 2031F |
6.3.3 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Instruments, 2021- 2031F |
6.3.4 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Software and Services, 2021- 2031F |
6.4 Philippines Preimplantation Genetic Screening (PGS) Technology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Maternity Centers, 2021- 2031F |
6.4.3 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Fertility Clinics, 2021- 2031F |
6.4.4 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Hospitals, Diagnostic Labs, 2021- 2031F |
6.4.5 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Service Providers, 2021- 2031F |
6.4.6 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.4.7 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.5 Philippines Preimplantation Genetic Screening (PGS) Technology Market, By Test Type |
6.5.1 Overview and Analysis |
6.5.2 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Chromosomal Abnormalities, 2021- 2031F |
6.5.3 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By X-linked Diseases, Embryo Testing, 2021- 2031F |
6.5.4 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Aneuploidy Screening, 2021- 2031F |
6.5.5 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By HLA Typing, 2021- 2031F |
6.5.6 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Other, 2021- 2031F |
6.6 Philippines Preimplantation Genetic Screening (PGS) Technology Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Embryo HLA Typing for Stem Cell Therapy, 2021- 2031F |
6.6.3 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By IVF Prognosis, 2021- 2031F |
6.6.4 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Late Onset Genetic Disorders, 2021- 2031F |
6.6.5 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Inherited Genetic Disease, 2021- 2031F |
6.6.6 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Preimplantation Genetic Screening (PGS) Technology Market Import-Export Trade Statistics |
7.1 Philippines Preimplantation Genetic Screening (PGS) Technology Market Export to Major Countries |
7.2 Philippines Preimplantation Genetic Screening (PGS) Technology Market Imports from Major Countries |
8 Philippines Preimplantation Genetic Screening (PGS) Technology Market Key Performance Indicators |
9 Philippines Preimplantation Genetic Screening (PGS) Technology Market - Opportunity Assessment |
9.1 Philippines Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
9.2 Philippines Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Philippines Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Product and Services, 2021 & 2031F |
9.4 Philippines Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Philippines Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.6 Philippines Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Preimplantation Genetic Screening (PGS) Technology Market - Competitive Landscape |
10.1 Philippines Preimplantation Genetic Screening (PGS) Technology Market Revenue Share, By Companies, 2024 |
10.2 Philippines Preimplantation Genetic Screening (PGS) Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |